Adaptive Biotechnologies (ADPT) FCF Margin Growth (3y) (2021 - 2026)
Adaptive Biotechnologies (ADPT) FCF Margin Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 221.00 |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -921.00 |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 819.00 |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | -891.00 |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 175.00 |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 3,681.00 |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 896.00 |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 327.00 |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 54.00 |
| 10 | Adaptive Biotechnologies | 3.80 Bn | 3.58 Bn | 52.17 Mn | 15,121.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15,121.00 |
| Dec 31, 2025 | 3,446.00 |
| Sep 30, 2025 | 9,020.00 |
| Jun 30, 2025 | 10,087.00 |
| Mar 31, 2025 | 11,782.00 |
| Dec 31, 2024 | 13,734.00 |
| Sep 30, 2024 | 8,945.00 |
| Jun 30, 2024 | 13,774.00 |
| Mar 31, 2024 | 7,634.00 |
| Dec 31, 2023 | 10,557.00 |
| Sep 30, 2023 | 8,541.00 |
| Jun 30, 2023 | -13,136.00 |
| Mar 31, 2023 | -1,074.00 |
| Dec 31, 2022 | 8,816.00 |
| Sep 30, 2022 | 4,363.00 |
| Jun 30, 2022 | -4,326.00 |
| Mar 31, 2022 | -236,844.00 |
| Dec 31, 2021 | -9,932.00 |
| Sep 30, 2021 | -8,109.00 |